Ledger.Open graph →
SEC Form D · filed July 14, 2025

Renasant Bio, Inc

Offering
$25.5M
Sold
$25.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BERKELEY, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Evan Caplan · Berkeley, CADirectorKevin Bitterman · Berkeley, CADirectorEmily Conley · Berkeley, CAExec · DirectorDeborah Palestrant · Berkeley, CADirectorEvan Caplan · Berkeley, CADirectorDeborah Palestrant · Berkeley, CADirectorEmily Conley · Berkeley, CAExec · DirectorKevin Bitterman · Berkeley, CADirectorThomas Gustafson · Berkeley, CAExecJune Lee · Irvine, CADirectorJames B. Maguire · Gloucester, MADirectorCraig H. Deery · Gloucester, MADirectorWalter Suydam · Gloucester, MADirectorPaul R. Melbye · Dallas, TXExec · DirectorThomas Gustafson · Berkeley, CAExecJune Lee · Irvine, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗